The urea cycle in the liver of arthritic rats.
The urea cycle in the liver of adjuvant-induced arthritic rats was investigated using the isolated perfused liver. Urea production in livers from arthritic rats was decreased during substrate-free perfusion and also in the presence of the following substrates: alanine, alanine + ornithine, ammonia, ammonia + lactate, ammonia + pyruvate and glutamine but increased when arginine and citrulline + aspartate were the substrates. No differences were found with ammonia + aspartate, ammonia + aspartate + glutamate, aspartate, aspartate + glutamate and citrulline. Ammonia consumption was smaller in the arthritic condition when the substance was infused together with lactate or pyruvate but higher when the substance was simultaneously infused with aspartate or aspartate + glutamate. Glucose production tended to correlate with the smaller or higher rates of urea synthesis. Blood urea was higher in arthritic rats (+25.6%), but blood ammonia was lower (-32.2%). Critical for the synthesis of urea from various substrates in arthritic rats seems to be the availability of aspartate, whose production in the liver is probably limited by both the reduced gluconeogenesis and aminotransferase activities. This is indicated by urea synthesis which was never inferior in the arthritic condition when aspartate was exogenously supplied, being even higher when both aspartate and citrulline were simultaneously present. Possibly, the liver of arthritic rats has a different substrate supply of nitrogenous compounds. This could be in the form of different concentrations of aspartate or other aminoacids such as citrulline or arginine (from the kidneys) which allow higher rates of hepatic ureogenesis.
Yassuda Filho
Paulino
P
Laboratory of Liver Metabolism, University of Maringá, Brazil.
Bracht
Adelar
A
Ishii-Iwamoto
Emy Luiza
EL
Lousano
Sharlise Hasegawa
SH
Bracht
Livia
L
Kelmer-Bracht
Ana Maria
AM
D000641:Ammonia / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001169:Arthritis, Experimental / Q000378:metabolism*; D001224:Aspartic Acid / Q000494:pharmacology; D002956:Citrulline / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D018698:Glutamic Acid / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D010100:Oxygen / Q000378:metabolism; D010477:Perfusion; D019289:Pyruvic Acid / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D014508:Urea / Q000378:metabolism*
D002956:Citrulline; D001224:Aspartic Acid; D019344:Lactic Acid; D018698:Glutamic Acid; D000641:Ammonia; D019289:Pyruvic Acid; D014508:Urea; D005947:Glucose; D010100:Oxygen